Creo Medical Group Management
Management criteria checks 4/4
Creo Medical Group's CEO is Craig Gulliford, appointed in Jan 2012, has a tenure of 12.25 years. total yearly compensation is £677.45K, comprised of 41.3% salary and 58.7% bonuses, including company stock and options. directly owns 0.47% of the company’s shares, worth £591.04K. The average tenure of the management team and the board of directors is 10 years and 7.4 years respectively.
Key information
Craig Gulliford
Chief executive officer
UK£677.4k
Total compensation
| CEO salary percentage | 41.3% |
| CEO tenure | 12.3yrs |
| CEO ownership | 0.5% |
| Management average tenure | 10yrs |
| Board average tenure | 7.4yrs |
Recent management updates
Recent updates
Market Cool On Creo Medical Group PLC's (LON:CREO) Revenues Pushing Shares 26% Lower
Mar 02
Revenues Tell The Story For Creo Medical Group PLC (LON:CREO) As Its Stock Soars 29%
Dec 29Is Creo Medical Group (LON:CREO) Weighed On By Its Debt Load?
Oct 06Creo Medical (LON:CREO) Is In A Good Position To Deliver On Growth Plans
Feb 03
How Many Creo Medical Limited (LON:CREO) Shares Do Institutions Own?
Dec 09CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -UK£25m |
| Mar 31 2023 | n/a | n/a | -UK£26m |
| Dec 31 2022 | UK£677k | UK£280k | -UK£27m |
| Sep 30 2022 | n/a | n/a | -UK£28m |
| Jun 30 2022 | n/a | n/a | -UK£28m |
| Mar 31 2022 | n/a | n/a | -UK£26m |
| Dec 31 2021 | UK£1m | UK£280k | -UK£25m |
| Sep 30 2021 | n/a | n/a | -UK£23m |
| Jun 30 2021 | n/a | n/a | -UK£21m |
| Mar 31 2021 | n/a | n/a | -UK£21m |
| Dec 31 2020 | UK£949k | UK£280k | -UK£20m |
| Sep 30 2020 | n/a | n/a | -UK£19m |
| Jun 30 2020 | n/a | n/a | -UK£17m |
| Mar 31 2020 | n/a | n/a | -UK£17m |
| Dec 31 2019 | UK£1m | UK£675k | -UK£16m |
| Jun 30 2019 | n/a | n/a | -UK£13m |
| Mar 31 2019 | n/a | n/a | -UK£12m |
| Dec 31 2018 | UK£1m | UK£792k | -UK£10m |
Compensation vs Market: Craig's total compensation ($USD847.73K) is about average for companies of similar size in the UK market ($USD759.95K).
Compensation vs Earnings: Craig's compensation has been consistent with company performance over the past year.
CEO
Craig Gulliford (53 yo)
12.3yrs
Tenure
UK£677,445
Compensation
Mr. Craig Jonathan Gulliford serves as the Chief Executive Officer of Creo Medical Group plc since 2012. Mr. Gulliford served as Operations Director of Vix ACIS Limited (formerly ACIS Holdings Ltd). Mr. G...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 12.3yrs | UK£677.45k | 0.47% £ 591.0k | |
| Founder | 22.3yrs | UK£513.76k | 1.38% £ 1.7m | |
| CFO, Company Secretary & Executive Director | 7.8yrs | UK£513.39k | 0.81% £ 1.0m | |
| Chief Commercial Officer & Executive Director | 3.7yrs | UK£611.02k | 0.13% £ 159.6k | |
| Sales & Marketing Director | no data | no data | no data |
10.0yrs
Average Tenure
54.5yo
Average Age
Experienced Management: CREO's management team is seasoned and experienced (10 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 7.6yrs | UK£677.45k | 0.47% £ 591.0k | |
| Founder | 7.6yrs | UK£513.76k | 1.38% £ 1.7m | |
| CFO, Company Secretary & Executive Director | 7.8yrs | UK£513.39k | 0.81% £ 1.0m | |
| Chief Commercial Officer & Executive Director | 7.4yrs | UK£611.02k | 0.13% £ 159.6k | |
| Senior Independent Non-Executive Director | 2.4yrs | UK£56.00k | 0.39% £ 497.0k | |
| Independent Non-Executive Director | 4.2yrs | UK£56.00k | 0.036% £ 45.3k | |
| Independent Non-Executive Chairman | 7.3yrs | UK£86.00k | 0.089% £ 111.8k |
7.4yrs
Average Tenure
56yo
Average Age
Experienced Board: CREO's board of directors are considered experienced (7.4 years average tenure).